Medical Point App
Medical Point Mph App Store
İndir
Online İşlemler
Randevu Alın International Patient

Doktorlar

DOÇ.DR. CİHAN ALTIN

DOÇ.DR. CİHAN ALTIN

Doktor Bilgileri

Randevu Alın

Eğitim ve Uzmanlık

  • BAŞKENT ÜNİVERSİTESİ TIP FAKÜLTESİ

Hastalıklar

Tedavi Yöntemleri

Deneyim

  • 2005 – 2010 Başkent Üniversitesi Tıp Fakültesi – Uzmanlık
  • 2010 – Clevelan Clinic Girişimsel Kardiyoloji Eğitimi

Mesleki Üyelikleri

  • Türk Kardiyoloji Derneği
  • Türk Tabipleri Birliği
  • Avrupa Kardiyoloji Derneği (ESC)
  • Avrupa Kardiyovasküler Görüntüleme Derneği (EAVI)

Araştırma Yayınları

  1. Altin C, Sade LE, Gezmis E, Ozen N, Duzceker O, Bozbas H, Eroglu S, Muderrisoglu H. Assessment of Subclinical Atherosclerosis by Carotid Intima-Media Thickness and Epicardial Adipose Tissue Thickness in Prediabetes. Angiology. 2016 Nov;67(10):961-969. doi: 10.1177/0003319716643669. Epub 2016 Jul 11.
  2. Altin C, Kanyilmaz S, Koc S, Gursoy YC, Bal U, Aydinalp A, Yildirir A, Muderrisoglu H. Coronary anatomy, anatomic variations and anomalies: a retrospective coronary angiography study.Singapore Med J. 2015 Jun;56(6):339-45. doi: 10.11622/smedj.2014193.
  3. Altin C, Sade LE, Gezmis E, Yilmaz M, Ozen N, Muderrisoglu H. Assessment of epicardial adipose tissue and carotid/femoral intima media thickness in insulin resistance. J Cardiol. 2017 Jun;69(6):843-850. doi: 10.1016/j.jjcc.2016.08.006. Epub 2016 Sep 7.
  4. Altin C, Yilmaz M, Ozsoy HM, Gezmis E, Balci S, Tekindal MA, Sade LE, Muderrisoglu H. Assessment of epicardial fat and carotid intima media thickness in gestational hypertension. J Obstet Gynaecol Res. 2018 Jun;44(6):1072-1079. doi: 10.1111/jog.13631
  5. Altin C, Erol V, Aydin E, Yilmaz M, Tekindal MA, Sade LE, Gulay H, Muderrisoglu H. Impact of weight loss on epicardial fat and carotid intima media thickness after laparoscopic sleeve gastrectomy: A prospective study. Nutr Metab Cardiovasc Dis. 2018 May;28(5):501-509. doi:10.1016/j.numecd.2018.02.001. Epub 2018 Feb 9.
  6. Altin C, Sade LE, Demirtas S, Karacaglar E, Kanyilmaz S, Simsek V, Ayhan A, Muderrisoglu H. Effects of Paclitaxel and Carboplatin combination on mechanical myocardial and microvascular functions: a transthoracic Doppler echocardiography and two-dimensional strain imaging study. Echocardiography. 2015 Feb;32(2):238-47. doi: 10.1111/echo.12621. Epub 2014 May 9.
  7. Altay H, Altın C, Coner A, Muderrisoglu H, Giray S. Parathyroid Hormone and Ischemic Cerebrovascular Event. Endocr Metab Immune Disord Drug Targets. 2019;19(8):1134-1140. doi: 10.2174/1871530319666190215150410.
  8. Sinan ÜY, Ekmekçi A, Özbay B, Akyıldız Akçay F, Bekar L, Koza Y, Bolat İ, Kocabaş U, Zoghi M; Collaborators. The real-life data of hospitalized patients with heart failure: On behalf of the Journey HF-TR study investigators. Anatol J Cardiol. 2019 Jan;21(1):25-30. doi: 10.14744/AnatolJCardiol.2018.50880.
  9. Altin C, Askin U, Gezmis E, Muderrisoglu H. Piezogenic Pedal Papules with Mitral Valve Prolapse. Indian J Dermatol. 2016 Mar-Apr;61(2):234. doi: 10.4103/0019-5154.177803.
  10. Altın C, Sakallıoğlu O, Gezmiş E, Müderrisoğlu H. Author's reply. Anatol J Cardiol. 2015 Jun;15(6):509-10.
  11. Altın C, Güllü H, Bilgel ZG, Yılmaz M, Canpolat T, Gülcan Ö. A Rare Cause of Left Ventricular Mass: Cardiac Hemangioma. Balkan Med J. 2018 Jul 24;35(4):348-349. doi: 10.4274/balkanmedj.2017.1334. Epub 2018 Mar 28.
  12. Altın C, Sade LE. Highlights from EuroEcho-Imaging 2014. Anatol J Cardiol. 2015 Mar;15(3):267-8. doi: 10.5152/akd.2015.0101.
  13. Yılmaz M, Altın C, Tekin A, Erol T, Arer İ, Nursal TZ, Törer N, Erol V, Müderrisoğlu H. Assessment of Atrial Fibrillation and Ventricular Arrhythmia Risk after Bariatric Surgery by P Wave/QT Interval Dispersion. Obes Surg. 2018 Apr;28(4):932-938. doi: 10.1007/s11695-017-2923-z.
  14. Aydin E, Altin C, Özcan Söylev G, Tekindal MA, Ağildere M.Assessment of Subclinical Atherosclerosis in Vitamin D Deficiency. Ultrasound Q. 2019 Jun;35(2):142-146. doi: 10.1097/RUQ.0000000000000386.
  15. Çoner A, Çiçek D, Akıncı S, Balcıoğlu S, Altın C, Müderrisoğlu H. Mid-term clinical outcomes of new generation drug-eluting stents for treatment of diffuse coronary artery disease. Turk Kardiyol Dern Ars. 2018 Dec;46(8):659-666. doi: 10.5543/tkda.2018.10.5543/tkda.2018.62678.
  16. Yılmaz M, Altın C, Tekin A, Arer İ, Yabanoğlu H, Çalışkan K, Moray G, Özin B, Müderrsioğlu H, Haberal M.Assessment of Atrial Fibrillation and Ventricular Arrhythmia Risk After Transplant in Patients With End-Stage Renal Disease by P-wave/QT Interval Dispersion, T-Wave Peak-End Interval, and T-Wave Peak-End/QT Interval Ratio. Exp Clin Transplant. 2018 Aug 6. doi: 10.6002/ect.2017.0313.
  17. Bozkurt Yilmaz HE, Yilmaz M, Şen N, Altin C, Ünsal ZE, Tekin A, Akçay Ş.Assessment of atrial fibrillation and ventricular arrhythmia risk in patients with asthma by P wave/corrected QT interval dispersion. Eur Rev Med Pharmacol Sci. 2018 Feb;22(3):756-762. doi:10.26355/eurrev_201802_14308.
  18. Demirtaş Inci S, Sade LE, Altın C, Pirat B, Erken Pamukcu H, Yılmaz S, Müderrisoğlu H. Subclinical myocardial dysfunction in liver transplant candidates determined using speckle tracking imaging. Turk Kardiyol Dern Ars. 2019 Dec;47(8):638-645. doi: 10.5543/tkda.2019.94728.
  19. Çoner A, Gençtoy G, Akinci S, Altin C, Müderrisoğlu H. Assessment of vascular inflammation and subclinical nephropathy in exaggerated blood pressure response to exercise test. Blood Press Monit. 2019 Jun;24(3):114-119. doi: 10.1097/MBP.0000000000000378.
  20. Okuyan H, Altın C. Heart failure induced by itraconazole. Indian J Pharmacol. 2013 Sep-Oct;45(5):524-5. doi: 10.4103/0253-7613.117751.
  21. Aydın E, Altın C, Sakallıoğlu O, Yılmaz M, Gezmiş E, Elif Sade L, Müderrisoğlu H. Epicardial Adipose Tissue Thickness and Carotid Intima-Media Thickness in Hemodialysis Patients. Acta Cardiol Sin. 2017 May;33(3):266-272. doi: 10.6515/acs20161023a.
  22. Altın C, Yılmaz M, Gezmiş E. Is echocardiographic epicardial adipose tissue thickness measurement a reliable and reproducible method for risk stratification? Anatol J Cardiol. 2015 Sep;15(9):769. doi: 10.5152/AnatolJCardiol.2015.6464.
  23. Altin C, Ozturkeri OA, Gezmis E, Askin U. Angioedema due to the new oral anticoagulant rivaroxaban. Ann Card Anaesth. 2014 Apr-Jun;17(2):173-4. doi: 10.4103/0971-9784.129888.
  24. Okuyan H, Altin C, Arihan O. Anaphylaxis during intravenous administration of amiodarone. Ann Card Anaesth. 2013 Jul-Sep;16(3):229-30. doi: 10.4103/0971-9784.114251.
  25. Altin C, Sade LE, Gezmis E, Muderrisoglu H. Who is Guilty of Subclinical Atherosclerosis in Prediabetes? Chicken or Egg Causality Paradox Between Insulin Resistance and Epicardial Fat. Angiology. 2016 Nov;67(10):972. doi: 10.1177/0003319716654081. Epub 2016 Jul 11.
  26. Altın C, Sakallıoğlu O, Gezmiş E, Müderrisoğlu H. A novel oral anticoagulant, dabigatran, in acute renal infarction. Anatol J Cardiol. 2015 Feb;15(2):158-9. doi: 10.5152/akd.2015.5837. Epub 2015 Jan 21.
  27. Türk UÖ, Alioğlu E, Tunçer E, Özpelit ME, Pekel N, Tengiz İ, Çetin N, Dalgıç O, Topaloğlu C, Bilgin N, Altın C, Özdemirkıran T, Tülüce K, Türkoğlu Eİ, Özpelit E. Design and rationale of dabigatran's stroke prevention in real life in Turkey (D-SPIRIT). Turk Kardiyol Dern Ars. 2016 Apr;44(3):221-7. doi: 10.5543/tkda.2015.37209.
  28. Altinel F, Altin C, Gezmis E, Altinors N. Cortical membranectomy in chronic subdural hematoma: Report of two cases. Asian J Neurosurg. 2015 Jul-Sep;10(3):236-9. doi: 10.4103/1793-5482.161184.
  29. Yılmaz M, Bozkurt Yılmaz HE, Şen N, Altın C, Tekin A, Müderrisoğlu H. Investigation of the relationship between asthma and subclinical atherosclerosis by carotid/femoral intima media and epicardial fat thickness measurement. J Asthma. 2018 Jan;55(1):50-56. doi: 10.1080/02770903.2017.1313272. Epub 2017 Apr 28.
  30. Yılmaz M, Altın C, Özyıldız A, Müderrisoğlu H. Are oxidative stress markers helpful for diagnosing the disease and determining its complexity or extent in patients with stable coronary artery disease? Turk Kardiyol Dern Ars. 2017 Oct;45(7):599-605. doi: 10.5543/tkda.2017.80733.
  31. Altın C, Kanyılmaz S, Baysal S, Özin B. QT interval prolongation due to metronidazole administration. Anadolu Kardiyol Derg. 2011 Aug;11(5):468-9. doi: 10.5152/akd.2011.120. Epub 2011 Jul 6.
  32. Bozbas H, Altin C, Yildirir A, Sade E, Gulmez O, Gultekin B, Sezgin A, Muderrisoglu H. Lipid profiles of patients with a transplanted heart before and after the operation. Transplant Proc. 2008 Jan-Feb;40(1):263-6. doi: 10.1016/j.transproceed.2007.11.043.
  33. Karacaglar E, Atar I, Altin C, Yetis B, Cakmak A, Bayraktar N, Coner A, Ozin B, Muderrisoglu H. The Effects of Niacin on Inflammation in Patients with Non-ST Elevated Acute Coronary Syndrome. Acta Cardiol Sin. 2015 Mar;31(2):120-6. doi: 10.6515/acs20140630e.
  34. Koç S, Ozin B, Altın C, Altan Yaycıoğlu R, Aydınalp A, Müderrisoglu H. Evaluation of circulation disorder in coronary slow flow by fundus fluorescein angiography. Am J Cardiol. 2013 Jun 1;111(11):1552-6. doi: 10.1016/j.amjcard.2013.01.324. Epub 2013 Mar 25.
  35. Altay H, Altin C, Coner A, Muderrisoglu H. Normal coronary artery patient presenting with left ventricular aneurysm. Case Rep Med. 2011;2011:183050. doi: 10.1155/2011/183050. Epub 2011 Aug 7.
  36. Pirat B, Bozbas H, Simsek V, Yildirir A, Sade LE, Gursoy Y, Altin C, Atar I, Muderrisoglu H. Impaired coronary flow reserve in patients with metabolic syndrome. Atherosclerosis. 2008 Nov;201(1):112-6. doi: 10.1016/j.atherosclerosis.2008.02.016. Epub 2008 Feb 21.
  37. Bozbaş H, Karaçağlar E, Ozkan M, Bozbaş SS, Eyüboğlu FÖ, Sade E, Altin C, Polat E, Sezgin A, Müderrisoğlu H.Transplant Proc. 2013;45(10):3538-41. doi: 10.1016/j.transproceed.2013.08.103.
  38. Bozbas H, Altin C, Karacaglar E, Kanyilmaz S, Yildirir A, Muderrisoglu H, Haberal M. The prevalence and types of cardiovascular disease in patients with end-stage renal disease undergoing renal transplantation. Transplant Proc. 2013;45(10):3478-80. doi: 10.1016/j.transproceed.2013.08.102.
  39. Bozbas SS, Kanyilmaz S, Akcay S, Bozbas H, Altin C, Karacaglar E, Muderrisoglu H, Haberal M. Renal transplant improves pulmonary hypertension in patients with end stage renal disease. Multidiscip Respir Med. 2011 Jun 30;6(3):155-60. doi: 10.1186/2049-6958-6-3-155.
  40. Bozbas H, Pirat B, Yildirir A, Simşek V, Sade E, Eroglu S, Atar I, Altin C, Demirtas S, Ozin B, Muderrisoglu H. Coronary flow reserve is impaired in patients with aortic valve calcification. Atherosclerosis. 2008 Apr;197(2):846-52. doi: 10.1016/j.atherosclerosis.2007.07.036.
  41. Bozbas H, Pirat B, Yildirir A, Simşek V, Sade E, Altin C, Muderrisoglu H.Mitral annular calcification associated with impaired coronary microvascular function. Atherosclerosis. 2008 May;198(1):115-21. doi: 10.1016/j.atherosclerosis.2007.09.044. Epub 2007 Nov 14.
  42. Altın C, Öztürkeri ÖA, Gezmiş E, Müderrisoğlu H.A clinical dilemma about a new oral anticoagulant treatment. Anadolu Kardiyol Derg. 2014 Dec;14(8):748-9. doi: 10.5152/akd.2014.5652. Epub 2014 Oct 23.
  43. Altin C, Izmir A, Osmanoğlu S, Gezmiş E, Sağduyu A. A rare cause of circulatory shock. Anadolu Kardiyol Derg. 2014 Sep;14(6):553-4. doi: 10.5152/akd.2014.5581.
  44. Çoner A, Akıncı S, Akküçük MH, Altın C, Müderrisoğlu H. Admission Tpe interval predicts reperfusion success in STEMI patients treated with fibrinolytic agents. Turk Kardiyol Dern Ars. 2020 Jan;48(1):49-57. doi: 10.5543/tkda.2019.84789.
  45. Kocabaş U, Sinan ÜY, Aruğaslan E, Kurşun M, Çoner A, Özcan Çelebi Ö, Öztürk C, Dalgıç O, Türkoğlu EI, Kemal HS, Gazi E, Altın C, Zoghi M. Clinical characteristics and in-hospital outcomes of acute decompensated heart failure patients with and without atrial fibrillation. Anatol J Cardiol. 2020 Apr;23(5):260-267. doi: 10.14744/AnatolJCardiol.2020.94884.
  46. Güneşli A, Yılmaz M, Altın C, Gezmiş E, Yabanoğlu H, Erol V.Assessment of Carotid Artery Distensibility and Elasticity After Laparoscopic Sleeve Gastrectomy: a Prospective Study. Obes Surg. 2020 Nov;30(11):4300-4306. doi: 10.1007/s11695-020-04725-8.
  47. Karacaglar E, Sade LE, Aydinalp A, Altin C, Müderrisoglu H. Bioptome injury to the tricuspid valve in a cardiac allograft recipient visualized by three-dimensional echocardiography. Eur J Echocardiogr. 2011 Jun;12(6):453. doi: 10.1093/ejechocard/jer038. Epub 2011 Apr 22.
  48. Aydinalp A, Atar I, Altin C, Gülmez O, Atar A, Açikel S, Bozbaş H, Yildirir A, Müderrisoğlu H. Platelet function analysis with two different doses of aspirin. Turk Kardiyol Dern Ars. 2010 Jun;38(4):239-43.
  49. Bozbas SS, Akcay S, Altin C, Bozbas H, Karacaglar E, Kanyilmaz S, Sayin B, Muderrisoglu H, Haberal M. Pulmonary hypertension in patients with end-stage renal disease undergoing renal transplantation. Transplant Proc. 2009 Sep;41(7):2753-6. doi: 10.1016/j.transproceed.2009.07.049.
  50. Altın C, Sade E, Bilezikçi B, Müderrisoğlu H. An acute coronary syndrome patient: is this atherosclerosis? Anadolu Kardiyol Derg. 2013 Sep;13(6):600-2. doi: 10.5152/akd.2013.202. Epub 2013 Sep 10.

Sağlık Rehberi

MitraClip ve TriClip Nedir? 25 Kasım 2024 MitraClip ve TriClip Nedir? SAĞLIK
Trigliserid Nedir? Kolesterolden Farkı Nedir? 25 Kasım 2024 Trigliserid Nedir? Kolesterolden Farkı Nedir? SAĞLIK
Nazal Septum Perforasyonu Nedir? 23 Ekim 2024 Nazal Septum Perforasyonu Nedir? SAĞLIK
Anjiyo Nedir? Anjiyo Nasıl Yapılır? 04 Ekim 2024 Anjiyo Nedir? Anjiyo Nasıl Yapılır? SAĞLIK
Tümünü Gör